Benign prostatic hyperplasia: Evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 3, 2009, Pages 641-648

  Kershaw, Lucy E ^a   Hutchinson, Charles E ^a   Buckley, David L ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Benign prostatic hyperplasia; DCE MRI; Precision; Reproducibility; Tracer kinetics

Indexed keywords

FINASTERIDE; TAMSULOSIN;

ADULT; AGED; ARTICLE; BOOTSTRAPPING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HUMAN; KINETICS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE; PROSTATE HYPERTROPHY; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; KINETICS; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC HYPERPLASIA; REPRODUCIBILITY OF RESULTS;

EID: 63449093488     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21674     Document Type: Article

References (41)

1. Laking GR, West C, Buckley DL, Matthews J, Price PM. Imaging vascular physiology to monitor cancer treatment. Crit Rev Oncol Hematol 2006;58:95-113.
2. Buckley DL, Shurrab AE, Cheung CM, Jones AP, Mamtora H, Kalra PA. Measurement of single kidney function using dynamic contrast-enhanced MRI: comparison of two models in human subjects. J Magn Reson Imaging 2006;24:1117-1123.
3. Jeukens CR, van den Berg CA, Donker R, et al. Feasibility and measurement precision of 3D quantitative blood flow mapping of the prostate using dynamic contrast-enhanced multi-slice CT. Phys Med Biol 2006;51:4329-4343.
4. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 2003;229:248-254.
5. Padhani AR, MacVicar AD, Gapinski CJ, et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 2001;218:365-374.
6. Kershaw LE, Logue JP, Hutchinson CE, Clarke NW, Buckley DL. Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging. Radiother Oncol 2008;88:127-134.
7. Rouviere O, Valette O, Grivolat S, et al. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor-correlation with biopsy findings. Urology 2004;63:922-927.
8. Jia G, Heverhagen JT, Henry H, et al. Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast- enhanced MRI. Magn Reson Imaging 2006;24:721-725.
9. Thorpe A, Neal D. Benign prostatic hyperplasia. Lancet 2003;361:1359-1367.
10. Noworolski SM, HenryRG, Vigneron DB, KurhanewiczJ. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 2005;53:249-255.
11. Kershaw LE, Buckley DL. Precision in measurements of perfusion and microvascular permeability with T(1)-weighted dynamic contrast-enhanced MRI. Magn Reson Med 2006;56:986-992.
12. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffus-able tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
13. St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab 1998;18:1365-1377.
14. Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging-initial experience. Radiology 2004;233:709-715.
15. Henderson E, Milosevic MF, Haider MA, Yeung IW. Functional CT imaging of prostate cancer. Phys Med Biol 2003;48:3085-3100.
16. Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfu-sion and treatment response in rectal cancer with multisection
17. CT: initial observations. Radiology 2005;234:785-792.
18. Purdie TG, Henderson E, Lee TY. Functional CTimaging ofangio- genesis in rabbit VX2 soft-tissue tumour. Phys Med Biol 2001;46:3161-3175.
19. Koh TS, Zeman V, Darko J, et al. The inclusion of capillary distribution in the adiabatic tissue homogeneity model of blood flow.Phys Med Biol 2001;46:1519-1538.
20. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995;33:564-568.
21. Liney GP, Turnbull LW, Lowry M, Turnbull LS, Knowles AJ, Hors-man A. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. Magn Reson Imaging 1997;15:1177-1186.
22. Brix G, Schad LR, Deimling M, Lorenz WJ. Fast and precise T1 imaging using a TOMROP sequence. Magn Reson Imaging 1990;8:351-356.
23. Lu H, Golay X, Pekar JJ, Van Zijl PC. Functional magnetic resonance imaging based on changes in vascular space occupancy. Magn Reson Med 2003;50:263-274.
24. Efron B. Bootstrap methods: another look at the jackknife. Ann Stat 1979;7:1-26.
25. Bland JM, Altman DG. Measurement error proportional to the mean. BMJ 1996;313:106.
26. Padhani AR, Hayes C, Landau S, Leach MO. Reproducibility of quantitative dynamic MRI ofnormal human tissues. NMR Biomed 2002;15:143-153.
27. Does MD, Beaulieu C, Allen PS, Snyder RE. Multi-component T1 relaxation and magnetisation transfer in peripheral nerve. Magn Reson Imaging 1998;16:1033-1041.
28. Stanisz GJ, Odrobina EE, Pun J, et al. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005;54:507-512.
29. Cheng HL, Wright GA. Rapid high-resolution T(1) mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity. Magn Reson Med 2006;55:566-574.
30. Kershaw LE. Measuring microvascular physiology using quantitative magnetic resonance imaging. Manchester, UK: University of Manchester; 2008. 216 p.
31. Fritz-Hansen T, Rostrup E, Ring PB, Larsson HB. Quantification of gadolinium-DTPA concentrations for different inversion times using an IR-turbo flash pulse sequence: a study on optimizing multislice perfusion imaging. Magn Reson Imaging 1998;16:893-899.
32. Lu H, Clingman C, Golay X, van Zijl PC. Determining the longitudinal relaxation time(T1) of blood at 3.0 Tesla. Magn Reson Med 2004;52:679-682.
33. Kjaer L, Thomsen C, Iversen P, Henriksen O. In vivo estimation of relaxation processes in benign hyperplasia and carcinoma of the prostate gland by magnetic resonance imaging. Magn Reson Imaging 1987;5:23-30.
34. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 2002;47:601-606.
35. Jayson GC, Waterton JC. Applications of dynamic contrast-enhanced MRI in oncology drug development. In: Jackson A, Buckley DL, Parker GJM, editors. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Berlin: Springer-Verlag; 2005. p 281-297.
36. Henderson E, Rutt BK, Lee TY. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging1998;16:1057-1073.
37. Weiger M, Boesiger P, Hilfiker PR, Weishaupt D, Pruessmann KP. Sensitivity encoding as a means of enhancing the SNR efficiency in steady-state MRI. Magn Reson Med 2005;53:177-185.
38. Roberts C, Issa B, Stone A, Jackson A, Waterton JC, Parker GJ. Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. J Magn Reson Imaging 2006;23:554-563.
39. Haacke EM, Filleti CL, Gattu R, et al. New algorithm for quantifying vascular changes in dynamic contrast-enhanced MRI independent of absolute T(1) values. Magn Reson Med 2007;58:463-472.
40. Inaba T. Quantitative measurements of prostatic blood flow and blood volume by positron emission tomography. J Urol 1992;148: 1457-1460.
41. Noworolski SM, Vigneron DB, Chen AP, Kurhanewicz J. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging2008;26:1071-1080.